$14.97
6.44% yesterday
Nasdaq, Apr 04, 10:00 pm CET
ISIN
IL0011316309
Symbol
MDWD
Sector
Industry

MediWound Ltd. Target price 2025 - Analyst rating & recommendation

MediWound Ltd. Classifications & Recommendation:

Buy
100%

MediWound Ltd. Price Target

Target Price $31.00
Price $14.97
Potential
Number of Estimates 5
5 Analysts have issued a price target MediWound Ltd. 2026 . The average MediWound Ltd. target price is $31.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 5 Analysts recommend MediWound Ltd. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MediWound Ltd. stock has an average upside potential 2026 of . Most analysts recommend the MediWound Ltd. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 20.22 24.35
8.19% 20.44%
EBITDA Margin -88.53% -110.87%
16.52% 25.24%
Net Margin -161.69% -127.27%
273.43% 21.29%

5 Analysts have issued a sales forecast MediWound Ltd. 2025 . The average MediWound Ltd. sales estimate is

$24.4m
Unlock
. This is
20.44% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$25.9m 28.03%
Unlock
, the lowest is
$23.5m 16.22%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $20.2m 8.19%
2025
$24.4m 20.44%
Unlock
2026
$30.8m 26.48%
Unlock
2027
$40.4m 31.04%
Unlock
2028
$86.6m 114.49%
Unlock
2029
$134m 55.35%
Unlock

1 Analyst has issued an EBITDA forecast MediWound Ltd. 2025 . The average MediWound Ltd. EBITDA estimate is

$-27.0m
Unlock
. This is
50.84% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-27.0m 50.84%
Unlock
, the lowest is
$-27.0m 50.84%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-17.9m 26.06%
2025
$-27.0m 50.84%
Unlock
2026
$-29.6m 9.63%
Unlock

EBITDA Margin

2024 -88.53% 16.52%
2025
-110.87% 25.24%
Unlock
2026
-96.10% 13.32%
Unlock

4 MediWound Ltd. Analysts have issued a net profit forecast 2025. The average MediWound Ltd. net profit estimate is

$-31.0m
Unlock
. This is
6.45% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-28.6m 13.69%
Unlock
, the lowest is
$-31.9m 3.58%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-32.7m 304.00%
2025
$-31.0m 5.21%
Unlock
2026
$-26.2m 15.39%
Unlock
2027
$-19.7m 24.90%
Unlock
2028
$220k 101.12%
Unlock
2029
$21.5m 9,659.09%
Unlock

Net Margin

2024 -161.69% 273.43%
2025
-127.27% 21.29%
Unlock
2026
-85.13% 33.11%
Unlock
2027
-48.79% 42.69%
Unlock
2028
0.25% 100.51%
Unlock
2029
15.97% 6,288.00%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -3.03 -2.87
304.00% 5.28%
P/E negative
EV/Sales 5.43

4 Analysts have issued a MediWound Ltd. forecast for earnings per share. The average MediWound Ltd. EPS is

$-2.87
Unlock
. This is
6.51% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-2.65 13.68%
Unlock
, the lowest is
$-2.96 3.58%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-3.03 304.00%
2025
$-2.87 5.28%
Unlock
2026
$-2.43 15.33%
Unlock
2027
$-1.83 24.69%
Unlock
2028
$0.02 101.09%
Unlock
2029
$1.99 9,850.00%
Unlock

P/E ratio

Current -4.87 73.75%
2025
-5.21 6.98%
Unlock
2026
-6.16 18.23%
Unlock
2027
-8.20 33.12%
Unlock
2028
748.50 9,228.05%
Unlock
2029
7.52 99.00%
Unlock

Based on analysts' sales estimates for 2025, the MediWound Ltd. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.54 22.01%
2025
5.43 16.99%
Unlock
2026
4.29 20.93%
Unlock
2027
3.28 23.69%
Unlock
2028
1.53 53.38%
Unlock
2029
0.98 35.63%
Unlock

P/S ratio

Current 8.33 15.11%
2025
6.92 16.97%
Unlock
2026
5.47 20.93%
Unlock
2027
4.17 23.69%
Unlock
2028
1.95 53.38%
Unlock
2029
1.25 35.63%
Unlock

Current MediWound Ltd. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 20 2025
Craig-Hallum
Locked
Locked
Locked Feb 28 2025
HC Wainwright & Co.
Locked
Locked
Locked Jan 10 2025
HC Wainwright & Co.
Locked
Locked
Locked Nov 27 2024
HC Wainwright & Co.
Locked
Locked
Locked Oct 11 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 20 2025
Locked
Craig-Hallum:
Locked
Locked
Feb 28 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jan 10 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 27 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Oct 11 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today